CRISPR Restores Muscle Function in Mice

Scientists use the gene-editing tool to treat animals with a rare form of congenital muscular dystrophy.

By | July 17, 2017

ISTOCK, DRA_SCHWARTZUsing CRISPR, researchers have successfully treated congenital muscular dystrophy type 1A (MDC1A), a rare disease that can lead to severe muscle wasting and paralysis, in mice. The team was able to restore muscle function by correcting a splicing site mutation that causes the disorder, according to a study published today (July 17) in Nature Medicine

“Instead of inserting the corrected piece of information, we used CRISPR to cut DNA in two strategic places,” study coauthor Dwi Kemaladewi, a research fellow at the Hospital for Sick Children (Sick Kids) in Toronto, explains in a statement. “This tricked the two ends of the gene to come back together and create a normal splice site.”

By targeting both the skeletal muscles and peripheral nerves, the team was able to improve the animals’ motor function and mobility. “This is important because the development of therapeutic strategies for muscular dystrophies have largely focused on improving the muscle conditions,” Kemaladewi says in the release. “Experts know the peripheral nerves are important, but the skeletal muscles have been perceived as the main culprit in MDC1A and have traditionally been the focus of treatment options.”

“The robustness of the correction we see in animal models to me is very encouraging,” Amy Wagers, a biologist at Harvard University who was not involved in this study, tells the Toronto Star.

See “CRISPR Improves Disease in Adult Mice

Wagers’s group and others have used CRISPR to fix a protein deficiency in adult mice with another rare muscle disease, Duchenne muscular dystrophy (DMD). Kemaladewi and colleagues have also tackled this disorder—in a 2015 study, their team used the gene editing tool to remove a duplicated gene and restore protein function in the cells of a patient with DMD.

See “CRISPR Therapy in a Dish

“For the first time it’s possible to think about—and this is still at the thinking stage, let’s be clear—the possibilities of gene correction in humans with these diseases,” Janet Rossant, a stem cell and developmental biologist at Sick Kids who was not involved in the research, tells the Toronto Star.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. 2017 Top 10 Innovations
    Features 2017 Top 10 Innovations

    From single-cell analysis to whole-genome sequencing, this year’s best new products shine on many levels.

  2. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  3. Antiviral Immunotherapy Comes of Age
    News Analysis Antiviral Immunotherapy Comes of Age

    T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 

  4. The Rising Research Profile of 23andMe
    News Analysis The Rising Research Profile of 23andMe

    An exploration of the genetics of earlobe attachment is just the latest collaborative research project to come out of the personal genetic testing company.

FreeShip